FASLG and autoimmune polyendocrinopathy: In 2015, Erkan et al. investigated the potential beneficial effects of statins in 24 aPL-positive patients, including 8 with primary APS, 5 primary aPL carriers, 7 with SLE-related APS, and 4 SLE aPL carriers.